Exclusive dermatology updates brought to you by the Journal of Drugs in Dermatology (JDD) online editorial team. Stay up-to-date on dermatology and aesthetic news, conference coverage, featured articles and more.
JDD Online News
From the Vault: Prospective single arm study reports sustained gains in firmness and hydration after cell free autologous injections We pulled this article from the JDD vault. A prospective, single…
Rethinking Hydroquinone: A JDD Review Every Dermatologist Should See Did you catch the latest JDD review on hydroquinone? This concise review revisits hydroquinone’s place in treating hyperpigmentation, examining its clinical…
Eruptive Lentiginosis After Biologic Therapy Results and Literature Review in JDD Have you read this latest article from the JDD? A new case report plus systematic review addresses eruptive lentiginosis…
Rethinking Dermatoporosis: Could the Dermoepidermal Junction Initiate Regenerative Repair? Have you had a chance to check out this article from the JDD? A new paper proposes that the dermoepidermal junction,…
Over 70 Submissions Focused on Dermatology for Skin of Color In April, as the official media partner of Skin of Color Update (SOCU), JDD published the SOCU 2025 Abstract Poster…
Curated by the JDD Editors Missed any of our April highlights? April is our immunodermatology issue and is packed with intriguing articles, and you’ll want to start to dive in!…
JDD Survey: How Dermatology Program Directors Are Responding to Step 1 Pass/Fail Have you read this article from the JDD? A new survey of dermatology residency program directors examine how…
Phase 3 data report rapid, clinically meaningful symptom reduction with a tolerable safety profile; early hidradenitis suppurativa signals broaden interest Hot off the pages of JDD, this timely review synthesizes…
Do the Eyes Have It? Corticosteroid Use and Stewardship in Ophthalmology Guest: Dr. Sumayya Ahmad Steroids: beloved (maybe), feared (yup), and, when it comes to the eye, handled with just…
Survey reveals higher likelihood of reported delays in accessing melanoma care among patients with skin of color The National Psoriasis Foundation (NPF) has a new position statement that clarifies the…
Survey reveals higher likelihood of reported delays in accessing melanoma care among patients with skin of color Have you read one of the latest articles published in JDD titled, “Delays…
What’s New in Hair Restoration Check out this clip with Dr. Jacob Beer as he shares the latest advancements in hair restoration.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
Hair Disorders and Treatments Hair treatments have proliferated in the past several years. While prior treatment options were limited to topical minoxidil and oral finasteride for androgenetic alopecia (AGA),…
Topical tapinarof associated with rapid resolution of shin lichen planus in a treatment resistant patient This is a must-read case report in JDD. The report describes a 70-year-old woman with…
A practical review of efficacy, safety, and real world considerations for advanced practice providers This is a must-read JDD article on JAK inhibitors for alopecia areata. The review summarizes current…
From the Vault: Pulled due to increased interest in rare onychomycosis presentations This case report dates back to JDD’s April 2018 issue. It’s a case report describing a healthy 51-year-old…
Updated long term and real world evidence on efficacy and safety This is a must-read JDD article on brodalumab in plaque psoriasis. The review summarizes long term clinical trial findings,…
Dive into JDD’s hidradenitis suppurativa resources! Hidradenitis suppurativa (HS) is common, devastating, and often underdiagnosed - and in the past decade the therapeutic toolbox and clinic pathways have expanded rapidly.…
Expert panel issues practical, steroid sparing guidance for long term CHE care Have you read this article in March’s JDD? A seven dermatologist panel reviewed the evidence and used a…
A large real world analysis identifies small but measurable perioperative signals for sensory change and nausea after Mohs micrographic surgery A retrospective cohort study using the TriNetX research network compared…
Lab to Label training boosts dermatology resident confidence in OTC product counseling Have you read this article from the upcoming April issue of JDD? An IRB approved study assessed topical…
Check out our all-new JDD Video Abstract from Susan Taylor MD, who discusses Clinical Evaluation of a Thiamidol-Based Regimen With SPF Compared With SPF Alone for Facial Hyperpigmentation.
Curated by the JDD Editors Missed any of our March highlights? March is packed with intriguing articles, and you’ll want to start to dive in! Catch up with this curated…
A practical, consensus driven algorithm to help clinicians combine topical care and device therapies We wanted to share this February 2026 article that has been gaining a lot of attention.…
A large real world TriNetX analysis reports an association between antiviral treatment for oral or mucocutaneous HSV and lower rates of Alzheimer disease and dementia If you’ve missed this must-read…
Have you read this JDD review on Th17 pathway defects and chronic mucocutaneous candidiasis? We pulled this one from the JDD vault - a must read article that dates back…
A pediatric case links dupilumab therapy for atopic dermatitis with sustained hair regrowth in extensive alopecia areata Dive into this recent JDD Case Study A single-patient case report describes a…
Dive into JDD’s hair resources! You told us you wanted more on hair, so JDD listened. Hair disorders—from everyday androgenetic hair loss to the disruptive, emotionally fraught cases of alopecia…
Inhaled, Applied, Prescribed: Steroids Through the Allergy Lens Guest: Dr. Bob Geng We all reach for corticosteroids—whether it's that trusty tube, inhaler, or systemic burst (or maybe all of the…
Have you read this JDD consensus on advanced topical nonsteroidal therapies for atopic dermatitis? Dive into this recent article from the March issue! A seven-dermatologist expert panel used a structured…
Have you read this JDD consensus on advanced topical nonsteroidal therapies for atopic dermatitis? A recent retrospective analysis using the TriNetX research network compared patients with non scarring hair loss…
GLP-1 Receptor Agonist Use and Hidradenitis Suppurativa in Overweight Patients — Retrospective Findings from a Single Center Have you read this article in the latest JDD issue? A recent IRB-exempt…
From the Vault: In this article from JDD, a multi state BRFSS analysis finds higher skin cancer history in rural populations and In this article from the JDD vault, authors…
Have you read this JDD case report on combination therapy for dissecting cellulitis of the scalp? Have you read this article in JDD? This case report describes two men, ages…
Check out our all-new JDD Video Abstract from Benjamin Ungar MD, who discusses Molecular Insights: Immune and Barrier Dysregulation in Seborrheic Dermatitis.
JDD study on biologics and cardiometabolic Dive into this March article! A large retrospective analysis using the TriNetX research network examined adults with hidradenitis suppurativa who were treated with biologics…
From the Vault: Noninvasive RNA from Tape Strips Differentiates AK from SCC In this article from the JDD vault, authors report a single center study that used adhesive tape strips…
Retrospective JDD study finds minocycline or doxycycline (100 mg twice daily) led to meaningful improvement in inflammatory gingival OLP in two months In a recent JDD report of 254 biopsy‑confirmed…
Lilly published the results of a Phase 3b clinical trial that showed treatment with concomitant Taltz (ixekizumab) and Zepbound (tirzepatide) was superior to ixekizumab alone in patients with active psoriatic…
In this article from JDD: Excimer laser delivers measurable PASI gains but evidence is limited A JDD meta‑analysis of 308 nm excimer laser treatment for plaque psoriasis pooled four clinical…
A JDD retrospective review links generalized disease to higher comorbidity burden and reports favorable response to pentoxifylline In this article from JDD’s February 2026’s issue, authors present a single center,…
Curated by the JDD Editors Missed any of our February highlights? February is packed with intriguing articles, and you’ll want to start to dive in! Catch up with this curated…
Behind the Bottle Part Deux: A Scientific, Socratic Squawk on Sensitive and Susceptible Skin Guest: Dr. Peter Lio The JDD Podcast returns with Part 2 of "Behind the Bottle", hosted…
From the Vault: A JDD survey of dermatology residents highlights concerns among underrepresented groups that may influence interest in Mohs micrographic surgery and dermatologic oncology fellowships In this article from…
Check out our all-new JDD Video Abstract from Seemal R. Desai, MD who discusses Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation.
Public health messaging misses the mark on Monkeypox and HIV A cross‑jurisdiction survey of publicly available Monkeypox and HIV materials from state, large metropolitan and select non‑metro U.S. health departments…
Ten Years, One Live Celebration: Join the conversation We were proud to celebrate a remarkable milestone at ODAC 2026, held January 16-19, 2026. It was a fitting place to honor…
In skin of color, halo phenomena can mask benign lesions; biopsy and dermoscopic‑pathologic correlation remain essential It’s time to dive into one of our January JDD case reports ! A…
Barrier boost for acne care: A new gel moisturizer soothes, strengthens and lifts quality of life We’re highlighting a December 2025 article that features one of JDD’s most sought-after topics:…
Aesthetics Is Changing. Here’s What We’re Seeing? Most dermatologists have experienced a shift in patient preferences over the past several years. There is a shift toward a minimalist, natural appearance.…
Trials fall short on representation - Black patients underenrolled in MF/SS studies The February issue of JDD features a review of completed US interventional trials for mycosis fungoides and Sézary syndrome…
Case report shows dual IL‑17A/F blockade produced striking clinical and functional gains within one month in refractory ACH The February 2026 JDD issue features a case report about a 67‑year‑old…
Combined Relabotulinum Toxin A frontalis modulation with NASHA™ gel skinboosters for the temples yields natural‑looking wrinkle softening and lasting skin quality gains beyond six months The Oncoderm Resource Center on…
Medscape highlighted a January Journal of Drugs in Dermatology study on the incidence of skin and hair effects from GLP-1 agonists. The study, “Cutaneous Adverse Events Associated With GLP-1 Receptor…
Case report: six weeks of gentian violet and trichloroacetic acid peel produced marked healing in dominant dystrophic epidermolysis bullosa with minimal discomfort The February 2026 JDD issue features a case…
Combined Relabotulinum Toxin A frontalis modulation with NASHA™ gel skinboosters for the temples yields natural‑looking wrinkle softening and lasting skin quality gains beyond six months A preliminary clinical series tested…
From the Vault: Review of the last decade finds biological rationale for skin and hair benefits, yet no FDA approvals and major gaps in standardization and clinical data Dive into…
Curated by the JDD Editors Missed any of our January highlights? January is our Aesthetics issue and it’s packed with intriguing articles–start to dive in! Catch up with this curated…
Systematic review finds Astragalus membranaceus compounds offer photoprotection, collagen support and even telomere benefits, but larger trials are needed A PRISMA systematic review of studies from 2015-2025 highlights growing preclinical…
2024 Asia‑Pacific survey of 204 Thermage users finds ideal candidates in their 40s, rising confidence, common same‑day combos with injectables, and practical tips on tips, settings and safety InA 2024…
Case Report: Rare post‑booster pigment change - photodistributed hyperpigmentation reported after COVID‑19 vaccination Dive into one of JDD’s latest case reports ! A 70‑year‑old woman developed a diffuse blue‑grey, photodistributed…
From the Vault: Vitiligo trials lag on diversity - US studies underrepresent non‑White and Hispanic patients We are pulling this article from the JDD vault. It’s a July 2024 article…
Medscape featured a December Journal of Drugs in Dermatology study on the link between isotretinoin and inflammatory bowel disease (IBD). The study, “Isotretinoin Does Not Increase the Risk of Inflammatory…
From the Vault: PLLA‑SCA injections deliver durable cheek wrinkle improvement and high patient satisfaction We are highlighting one of our popular articles from the vault: a January 2024 read that…
Test Your Knowledge! Join Dr. Alexis Carrington, Chief Dermatology Resident at George Washington University, to help understand dermatologic conditions across all skin tones. Decoding Derm: What’s the Diagnosis is a…
Title: Novel Treatments and Clinical Insights Shaping Dermatology As we head into the new year, it’s important to highlight some of the pieces that helped clarify the role of novel…
See JDD author Dr. Andrew Blauvelt bring cutting‑edge psoriasis science to life in GWU’s Dermatology Translational Science Lecture Series, and learn about his new Nature study on high‑induction risankizumab dosing.…
Check out our all-new JDD Video Abstract from Joshua Zeichner MD, who discusses Retrospective Review of Dermal Safety Studies of Organic Sunscreens.
Thiamidol shows rapid, sustained benefit for facial hyperpigmentation We’re highlighting a December 2025 article that we’re sure you’ll want to dive into! A 90‑patient randomized study found that thiamidol formulations…
Join Dr. Jared Jagdeo, a board certified dermatologist, to learn more about new innovations of SkinCeuticals. Dr. Jagdeo will present a review of the latest antioxidant science from SkinCeuticals. Faculty…
Join Dr. Ted Lain, Chief Medical Officer at Sanova Dermatology, and Star Walsh, R&D Director at Neutrogena®, for an informative webinar on the latest science and role of adjunctive OTC…
Coverage clears the way: Most large private insurers pay for Botox and friends for axillary hyperhidrosis In one of our January JDD articles, we reviewed public medical‑policy guidance from the…
Despite millennia of observation and modern understanding of HPV, treatment choices remain trade‑offs between efficacy, speed and tolerability From the Editor-in-Chief Dear Readers, As we look back on 2025, one…
Behind all sunscreen is a scientific story, the photobiology, toxicology and public perception. Yet, the science often gets lost in the noise of misconceptions and outdated narratives. Join Adam Friedman…
Minocycline ER spares the microbiome: A December JDD highlight In the December issue of JDD we wanted to highlight a randomized, double‑blind, placebo‑controlled microbiome study of DFD‑29 (minocycline hydrochloride extended‑release…
From the Vault: Fecal transplant may revive immunotherapy responses in melanoma We pulled this February 2024 vault article because it’s been a popular read. It’s a focused review of microbiota‑modulating…
Metabolic drugs for HS? GLP‑1 receptor agonists show promise beyond weight loss If you haven’t yet, dig into this recent JDD article about GLP-1 receptor agnosists and hidradenitis suppurativa. Hidradenitis…
Isotretinoin and IBD — large real‑world data offer reassurance In one of our recent JDD articles, a retrospective cohort using the TriNetX network compared acne patients exposed to long‑term, low‑dose…
Review highlights higher psychiatric comorbidity, systemic barriers to care, and the value of integrated psychodermatologic models This article in the December 2025 issue of JDD discusses how Hispanic and Latinx…
Now arrived for recently graduated dermatologists: the JDD Welcome Kit! The Journal of Drugs in Dermatology (JDD), together with generous sponsors, has sent these curated kits to the newest members…
Background: The objective of this survey was to obtain feedback and insights from United States dermatology healthcare professionals on their perceptions of sunscreens. Methods: This cross-sectional survey study launched online…
Join Dr. Zoe Diana Draelos, MD, as she presents data on over-the-counter product innovations from L'Oréal Dermatological Beauty's trusted brands: CeraVe and La Roche-Posay Dr. Draelos will discuss Xerosis Management…
Don’t lose platelets to the gel: simple tweaks boost PRP yield from thixotropic systems We are pulling out this must-read article from the vault. This brief report from the November…
Lessons learned from a challenging lived experience is a terrible thing to waste…which is why we would NEVER do so! In this episode of the JDD Podcast's Steroid Stewardship Series,…
Despite millennia of observation and modern understanding of HPV, treatment choices remain trade‑offs between efficacy, speed and tolerability Warts are caused by non‑enveloped double‑stranded DNA human papillomaviruses and, while two‑thirds…
Representation improving but not solved—Black patients still underrepresented in recent HS trials A review of ClinicalTrials.gov trials for hidradenitis suppurativa initiated between June 2020 and December 2024 identified five trials…
Case report: IL‑31 receptor blockade markedly reduced neuropathic pruritus and improved quality of life in a 52‑year‑old woman after standard therapies failed Scarring reflects replacement of normal dermis by fibroblast-driven,…
Navigating the New Dermatology Landscape: Billing, Virtual Care, and the Rise of DermTok In the past several years, managing and running a dermatology practice has changed drastically. These changes have…
Review places silicone and occlusion as first‑line topical therapy, with retinoids, pressure, corticosteroids and cannabinoids as situational tools amid limited high‑quality evidence Scarring reflects replacement of normal dermis by fibroblast-driven,…
Efficient history, targeted exam, selective labs and clear shared‑decision plans let dermatologists deliver meaningful vitiligo care in time‑pressed visits In routine practice, non‑segmental vitiligo (NSV) visits can be both brief…
Background: Psoriasis is a common skin condition that affects the physical and emotional well-being of patients. Moisturizers have been shown to significantly improve skin condition and quality of life in…
Case Report: Peristomal Pyoderma Gangrenosum After Colectomy — A Clinical Reminder for Dermatologists This JDD Case Report dives into how a 55‑year‑old woman developed rapidly progressive, painful cribriform ulcers with…
In Field (Cancerization) Tested: Patient and Provider Perspectives on Klisyri, guest host Dr. Vishal A. Patel, Associate Professor of Dermatology and Medicine/Oncology at the George Washington University School of Medicine…
What patients eat matters in HS: pro‑inflammatory diets worsen disease; anti‑inflammatory patterns and targeted supplements may help This literature review synthesizes recent studies connecting dietary patterns with hidradenitis suppurativa severity.…
Case report shows symptom improvement with 1.5% ruxolitinib cream after standard therapies failed A 72‑year‑old woman with refractory Benign Familial Pemphigus (Hailey‑Hailey disease) experienced persistent flares despite conventional management with…
From the Vault: A popular consensus paper recommends newborn‑to‑child barrier care with ceramide‑containing moisturizers to delay flares and reduce steroid need We pulled this widely read JDD article because it…
Test Your Knowledge! Join Dr. Alexis Carrington, Chief Dermatology Resident at George Washington University, to help understand dermatologic conditions across all skin tones. Decoding Derm: What’s the Diagnosis is a…
Curated by the JDD Editors Missed any of our November highlights? November is packed with intriguing articles–start to dive in! Catch up with this curated roundup from the JDD Editors—your…
From the Vault: Fecal microbiota transplant may revive ICI responses in metastatic melanoma We went into the JDD vault to highlight a focused review of microbiota‑modulating interventions in metastatic melanoma treated…
Dermatology HCPs overwhelmingly back practical sunscreens — social media blamed for most misinformation A cross‑sectional online survey of 723 U.S. dermatology healthcare professionals via the Dermsquared platform probed perceptions of…
Mohs proves highly effective for female genital skin cancers - pooled review reports ~95% cure A targeted systematic review of the literature identified 166 treated cases of extramammary Paget’s disease,…
Check out our all-new JDD Video Abstract from Zoe Diana Draelos, MD, who discusses Skin Barrier Benefits of a Natural Moisturizing Factor and Lipids-Based Moisturizer for Clinically Sensitive Skin.
Check Out Our Latest TSLS The field of dermatology continues to evolve at a rapid pace, bringing groundbreaking research from the lab to the clinic. As part of its ongoing…
Corticosteroids have been the effective, accessible, and familiar backbone of dermatologic therapy for decades. But with great power comes great responsibility. In this episode, podcast host Dr. Adam Friedman, Professor…
Niacinamide still useful — but high oral doses may carry cardiovascular risk A literature review confirms that oral nicotinamide (niacinamide) is a versatile, generally well‑tolerated tool in dermatology: it reduces…
L’Oréal Dermatological Beauty: Discover What’s New & Next in OTC Care from CeraVe and La Roche-Posay
Join Seemal Desai, MD, FAAD, as he presents the latest over-the-counter product innovations from L'Oréal Dermatological Beauty's trusted brands: CeraVe and La Roche-Posay. Dr. Desai will present new clinical and…
Ranked As A Top 10 Dermatology Podcast The JDD podcast, hosted by Dr. Friedman, was recently ranked as a top ten dermatology podcast by Feedspot. We are grateful for the…
Caffeine shows promise for hair loss, but evidence remains preliminary A systematic review identified nine studies—five randomized controlled trials, three prospective cohorts and one twin‑twin cohort—evaluating caffeine interventions for hair…
Breakthroughs in atopic dermatitis are redefining treatment from the inside out. Discover how new data on race, microbes, and patient preferences are transforming the way we think about AD. In…
Barrier boost with benefits - new topical cream raises filaggrin, hyaluronic acid and lipids while improving tolerability A novel topical cream moisturizer produced meaningful biological and clinical improvements in both…
Exosome complex after microneedling shows promising hair‑regrowth signals in a 30‑patient series In a 30‑subject study (15 men, 15 women; mean age 50.2 years) treated with an Exosome Regenerative Complex+…
Think beyond inflammation: SAIGE framing reframes pediatric AD prevention and care A seven‑expert global panel of pediatric dermatologists and dermatologists used a modified Delphi process to produce five consensus statements…
Dupilumab delivers — but many patients need more than monotherapy over time In a US retrospective cohort (OM1 PremiOM™ AD) of 5,200 patients who started dupilumab between 2017-2021 (208 children, 430…
Join Dr. Kachiu Lee, a board-certified cosmetic dermatologist, to learn more about new innovations of SkinCeuticals. Dr. Lee will share the latest integrated skincare science from SkinCeuticals, focusing on products…
Topical Steroid Withdrawal — What Your Patients Are Watching Online Topical steroid withdrawal (TSW) is an increasingly visible — and misunderstood — drug‑related dermatosis that can follow abrupt discontinuation of…
Rethinking AD — Beyond Inflammation Atopic dermatitis remains common and stubborn, especially in pediatric patients, because inflammation is only one part of a self‑reinforcing loop that includes microbiome disruption, neuroimmune…
Meet Dr. Theodore (Ted) J. Daly Theodore (Ted) J. Daly MD has been in private practice at Garden City Dermatology, New York, for nearly four decades. He received his medical…
From the Vault: Novel Strategy for Strengthening Dermatoporotic Skin by Managing Cellular Senescence
Microdosed Actives Target Dermal Senescence - A Surprising Lab Advance That Could Reshape Dermatoporosis Care Dermatoporosis —age‑related thinning and fragility of the skin driven by fibroblast dysfunction, ECM breakdown, and…
Influenza Vaccination and Arm Nodules: Uncovering a Hidden Risk A large propensity-matched cohort study using TriNetX data found that intramuscular influenza vaccination carries a 32% higher risk of developing subcutaneous…
Sunscreen ... our daily epi/dermal defense, our solar safeguard, our broad-spectrum BFF for life. Yet lurking in the shaded areas are unfounded fears: “Sunscreen causes cancer; Sunscreen is an endocrine…
Dermatology On-Call Data Uncover Trends in Hematology–Oncology Cutaneous Complications Oncodermatology consults for hematological malignancy patients often uncover therapy-related skin toxicities that can derail cancer treatment. In a retrospective review of…
Curated by the JDD Editors Missed any of our October highlights? October is our Atopic Dermatitis focused issue–start to dive in! Catch up with this curated roundup from the JDD…
Test Your Knowledge! Join Dr. Alexis Carrington, Chief Dermatology Resident at George Washington University, to help understand dermatologic conditions across all skin tones. Decoding Derm: What’s the Diagnosis is a…
Fast itch relief and comparable skin clearance at week 4 - a nonsteroidal option to note for mild-moderate AD In a phase 2, dose‑ranging trial, twice‑daily 1.5% ruxolitinib cream matched…
A simple 1% colloidal oatmeal regimen cut itch and improved eczema scores within days in toddlers A small open‑label study in children aged 3-72 months tested a twice‑daily 1% colloidal…
A multi-acid, antioxidant delivery approach that promises boost in radiance and texture without PIH. Worth a look for patients with FST V–VI Facial rejuvenation that's both effective and safe in…
Honoring The Life of a Giant in Dermatologic Surgery We are all mourning the untimely passing of our esteemed colleague and friend, Dr Ron Moy, in July 2025. Dr Moy…
Check out our all-new JDD Video Abstract from Zoe Diana Draelos, MD, who discusses Study of Adjuvant Sensitive-Skin Cleansings and Moisturizing Regimen in Plaque Psoriasis.
Acne Vulgaris... It pops up everywhere — in clinic, in conversation, and unfortunately, on our patients’ faces/trunks. While we’ve long leaned on prescription mainstays to zap zits, there’s a new family…
When One Target Isn’t Enough — Dual Therapy Clears Refractory ADW An adolescent with persistent, widespread atopic dermatitis failed topical therapy and dupilumab, then achieved only partial control on upadacitinib…
A Single‑Patient Signal That IL‑31 Blockade May Finally Tame The Relentless Itch Of Linear IgA Disease Linear IgA bullous dermatosis can be as much an itch disorder as a blistering…
Join JDD Podcast: Ask the Investigators as we celebrate almost a decade of dermatology insight with our trusted host, Dr. Adam Friedman. If you love learning with a smile, National…
Psoriatic Arthritis Awareness Day: Reddit Sentiment Meets a Crohn’s Conundrum On September 28, Psoriatic Arthritis Awareness Day invites dermatologists to look beyond the clinic and into the digital communities where patients…
Clascoterone Keeps Gaining Ground in Acne Two identical Phase 3 trials (plus a long‑term extension) randomized patients ≥12 years with moderate‑to‑severe acne to twice‑daily clascoterone 1% cream or vehicle for…
Small Channels, Smarter Delivery - A Practical Boost For Topical And Regenerative Approaches Microneedling is proving to be a low‑risk, clinic-friendly way to enhance topical therapies (most consistently 5% minoxidil, now…
Dupilumab in Diverse Skin — Are Adverse Events Really the Same? Atopic dermatitis isn’t one-size-fits-all: chronic type 2 inflammation, barrier dysfunction, and S. aureus colonization are core features, but presentation…
Aesthetic treatments are evolving faster than ever, from fillers and sunscreens to the promise (and debate) of exosomes. This month’s Re:View spotlights the studies shaping today’s practice and tomorrow’s possibilities.…
Revisiting A Vault Favorite On The Fragile‐Skin Syndrome And The Emerging Role Of Calcipotriene We’re pulling this article from our JDD vault because it’s one of our most popular reads.…
Healio profiled a July Journal of Drugs in Dermatology study on the affordability of dermatologist-recommended skincare products for atopic dermatitis. The study, “Socioeconomic Disparities in Gentle Skin Care Access for…
Moderate Evidence Points To Safety And Quality-Of-Life Gains In Hard-To-Treat Patients We’re pulling this article from our vault because it’s one of our most popular reads, and with good reason.…
Cadaveric Simulations And A Standardized Management Algorithm Significantly Boost Confidence In Handling Vascular Emergencies Soft-tissue filler injections carry a real risk of vascular compromise—tissue necrosis, vision loss, even stroke—with few…
Unmasking Allergic Contact Dermatitis from Nail Products Everyday nail products, from budget bottles to luxury gel overlays, harbor sensitizers that can spark not only periungual itching and inflammation but also…
Charting New Paths in Hair Restoration for Alopecia Awareness Month As Alopecia Awareness Month unfolds, dermatologists have an opportunity to explore the latest evidence-based strategies for hair loss —straight from…
Active ingredients play a critical role in the efficacy and safety of cosmeceuticals. Join Julie Ann Woodward, MD as she shares information on the efficacy and safety on a new…
A New US Consensus on Acneceuticals in the Management of Acne Vulgaris: From Concept to Clinical Practice Faculty Hilary Baldwin, MD Board-Certified Dermatologist Medical Director Acne Treatment & Research Center…
Test Your Knowledge! Join Dr. Alexis Carrington, Chief Dermatology Resident at George Washington University, to help understand dermatologic conditions across all skin tones. Decoding Derm: What’s the Diagnosis is a…
Structural Insights: What Makes Some IL-23 Biologics More Effective in Psoriasis Check our all-new video abstract from Christopher G. Bunick MD PhD, who gives structural insights into what makes some…
Oral Hyaluronic Acid Supplement: Efficacy in Skin Hydration, Elasticity, and Wrinkle Depth Reduction
Meta-analysis of RCTs Reveals Significant Gains In Hydration And Elasticity - With Wrinkle Reduction On The Horizon A new meta-analysis of seven randomized controlled trials offers dermatologists a fresh look…
Curated by the JDD Editors Missed any of our September highlights? September is our Aesthetics Treatment focused issue–start to dive in! Catch up with this curated roundup from the…
In this special edition of the JDD Podcast, host Dr. Adam Friedman flips the script on one of dermatology’s most recognizable voices, Dr. Jim Del Rosso, to explore the why,…
Harness Klotho Protein’s UV-Defying Power for Breakthrough Photoaging Repair A landmark 12-week clinical study reveals that Klotho Skin Serum, a cutting-edge, anti-aging skin serum enriched with the Klotho protein, delivers…
Did You Miss These? Must-Listen JDD Podcasts on Acne, Dyspigmentation & Oncodermatology! Dermatology is always evolving, and if you haven’t caught the latest 'Ask the Investigator' podcast episodes, you’re missing…
Harness Klotho Protein’s UV-Defying Power for Breakthrough Photoaging Repair Every day, more families are turning to beauty aisles with their kids in tow, and retailers are responding. Sephora’s new “Kids”…
Biofilms, Hard Nodules, and the Surprising Power of Hypochlorous Acid Most hyaluronic acid lumps after filler settle on their own, but a rare “delayed-onset” nodule can spell trouble—especially when it…
Switching from Dupilumab to Upadacitinib: Practice-Informing Evidence from LEVEL UP SWITCH This exclusive video interview with Dr. Christopher Bunick unveils the practice-changing insights of the LEVEL UP SWITCH study, designed…
Harness the Power of AGE Inhibition for Superior Post-Resurfacing Results A breakthrough split-face study shows that a targeted AGE-inhibitory moisturizer dramatically elevates post-resurfacing skincare outcomes for all skin tones. After…
Uncovering Hidden Autoimmune Threats In Healed Zoster Sites Sometimes the skin that’s healed from herpes zoster can harbor an unexpected surprise. In two striking cases, patients developed new autoimmune eruptions—discoid…
Zabalafin’s All-In-One Assault On Inflammation, Infection, Dryness, and Itch Atopic dermatitis has long been driven by a vicious circle—staph overgrowth, immune flare-ups, parched skin, and relentless itch that feed one…
Check out our all-new JDD Video Abstract from Gary S. Rogers, MD, who discusses Placental Allograft Reconstruction of Cutaneous Wounds Following Mohs Surgery: A Propensity Score-Matched Comparative Cost-Effectiveness Analysis.
Why CBD’s Skin-Deep Potential Is Both Promising—And Puzzling For Your Practice Over the past decade, CBD has gone from a niche curiosity to a bona fide buzzword in skincare. Acting…
Curated by the JDD Editors Missed any of our August highlights? August is our psoriasis issue–a must-read. Catch up with this curated roundup from the JDD Editors—your guide to must-read articles…
Recent Safety and Efficacy Data for Biologics in Psoriasis Treatment options for plaque psoriasis have proliferated significantly in the past decade, with an influx of biologics. With these seemingly interchangeable options,…
Welcome to our exclusive webinar, where we invite you to explore the intersection of beauty and science with Neutrogena®, a leader in the skincare industry. Join us as we delve…
A New Outreach Program Demonstrates How Targeted Education Can Transform Access To Dermatologic Care Since its launch in 2020, DermmunityTM, a community service program run by the USC Department of…
A Concise Look at the IMMPulse Trial Comparing Apremilast And Risankizumab In Moderate Plaque Psoriasis In a compelling video interview for the Journal of Drugs in Dermatology, Dr. Christopher Bunick…
Several media outlets covered an August Journal of Drugs in Dermatology survey on the perceived dermatologic side effects of cancer treatments and how those perceptions could impact a person’s decision…
As the most common inflammatory skin disease, Acne Vulgaris is unavoidable in our line of work. By default, we have to be Princes/Princesses of Pimples, though fortunately we have a…
Oatmeal Uncovered: Your New Ally in Skin Health Discover why colloidal oatmeal has earned its spot in modern dermatology. At the JDD Oats in Skincare Educational Resource Center, we’ve assembled…
Transforming Routine Visits into Early‐Warning Systems for Psoriatic Arthritis What if every psoriasis appointment could double as a stealth screening for psoriatic arthritis? In one of our latest JDD articles titled…
Rice Bran Reimagined: A New Frontier in Hair Health Could this ancient grain extract be the next go-to for patients battling
Rethinking Spironolactone Dosing in Female Pattern Hair Loss Could a lower dose of spironolactone offer relief to women struggling with thinning hair? Female pattern hair loss (FPHL) is a multifactorial condition…
Elevate your practice with the very latest clinical insights, case studies, and CME, all in one place. Discover the Acne Resource Center - your new go-to microsite for the very…
Check out our all-new JDD Video Abstract from Christopher G. Bunick, who discusses PDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact.
Boosting Psoriasis Outcomes with a Dual Strategy - Deucravacitinib Plus Calcipotriene/Betamethasone Foam Shows Lasting Benefits A promising new open-label study in our August issue highlights how adding topical calcipotriene/betamethasone dipropionate…
Scar Therapy Showdown—Triamcinolone Takes the Crown, but the Field Is Full of Contenders Are you reassessing your approach to hypertrophic and keloid scars? A PRISMA-guided review in the August 2025…
Listen Now! If you’ve been snoozing on the latest JDD "Ask the Investigator" podcast episodes, consider this your wake-up call! Hosted by the ever-insightful Dr. Adam Friedman and sponsored by…
Living with dandruff can be uncomfortable and frustrating. Join board-certified dermatologist Dr. Natasha Mesinkovska to learn about effective dandruff management strategies and discover CeraVe’s new, dermatologist-developed haircare system. Dr. Mesinkovska…
Case Reports Are Now Unlocked Access—Your Next Dermatology Obsession Is Just One Click Away! Did you know that the latest Case Reports in JDD are unlocked for everyone—and from here on…
Living with dandruff can be uncomfortable and frustrating for the 52 million Americans who have the condition. Join Dandruff affects 52 million Americans. Join Dr. Houshmand’s review of clinical data…
Catch Up on the Latest Think about the last time you saw real-world data reshape your treatment approach—what if you discovered that one of our most trusted biologics behaves differently…
Living with dandruff can be uncomfortable and frustrating for the 52 million Americans who have the condition. Join Dandruff affects 52 million Americans. Join Dr. Houshmand’s review of clinical data…
Check Out Our Latest TSLS The field of dermatology continues to evolve at a rapid pace, bringing groundbreaking research from the lab to the clinic. As part of its ongoing…
Living with dandruff can be uncomfortable and frustrating. Join board-certified dermatologist Dr. Natasha Mesinkovska to learn about effective dandruff management strategies and discover CeraVe's new, dermatologist-developed haircare system. Dr. Mesinkovska…
Did You Miss These? Missed any of our recent Video Abstracts? Catch up now! A Scientific Approach to Defining, Evaluating, and Treating Pre-Aging With a Cosmetic Regimen Containing a…
Botulinum Toxin for Hidradenitis Suppurativa? Early Evidence Looks Promising Hidradenitis suppurativa (HS) remains a challenging and often painful condition—one that disproportionately affects women, people of color, and underserved populations. With…
A Closer Look at Alopecia Areata in Black Patients: Are We Missing Key Diagnostic Clues? Alopecia areata (AA) is more prevalent in patients with skin of color —but how well…
Why Visible Light Protection Matters—Especially for Your Patients with Melasma and Deeper Skin Tones Sun protection isn’t just about UV rays anymore. Visible light, making up nearly half the sunlight…
Can Probiotics Help Psoriasis? This Study Says Yes—And Here’s Why You Should Pay Attention Could your next psoriasis treatment plan include probiotics? A randomized, double-blind, placebo-controlled trial published in JDD’s June…
Join Dr. Pearl Grimes, MD and Dr. Hawasatu Dumbuya, PhD, for an informative and interactive webinar on new research advances in broad-spectrum and visible light photoprotection needs and strategies for…
From the Vault: The Heterogeneity of Atopic Dermatitis Atopic dermatitis (AD) isn’t a single-symptom disease, and treating it like one may shortchange your patients. A focused review in a JDD…
Pregnancy-Related Pyoderma Gangrenosum: Misdiagnosed, Understudied, and Clinically Challenging A new systematic review sheds light on the rare but serious occurrence of pyoderma gangrenosum (PG) during pregnancy and the postpartum period,…
Lip Augmentation with HA Fillers: Anatomy, Technique, and Safety Essentials Pulling from the JDD vault, let’s revisit this January 2023 article. As demand for lip augmentation still grows, dermatologists are…
Hyperpigmentation Patients Report Low Satisfaction and Limited Awareness of Treatment Options A new cross-sectional survey reveals that hyperpigmentation, especially among patients with deeper skin tones, continues to be a significantly…
Curated by the JDD Editors Missed any of our July highlights? As the official partner of the Skin of Color Update , July is our “Bridging the Gap in Dermatology”…
Biologics for Mastocytosis? New Evidence Supports Targeted Treatment Success Could the next breakthrough for mastocytosis already be in your therapeutic toolbox? A new article in the July issue of JDD…
July Is Hyperpigmentation & Melasma Awareness Month – Did You Know We Have a Curated Resource Just for You? As summer sun peaks, so does your patients' concern about dark…
Test Your Knowledge! Join Dr. Alexis Carrington, Chief Dermatology Resident at George Washington University, to help understand dermatologic conditions across all skin tones. Decoding Derm: What’s the Diagnosis is a…
Lotion or Cream? A Fresh Look at Moisturizer Efficacy in Dry Skin Dry skin is more than just a nuisance, it’s a clinical challenge that affects comfort, barrier function, and,…
Catch Up on July’s Latest Case Report on Pincer Nail Relief Pincer nail deformity isn’t just unsightly, it’s painful, persistent, and notoriously difficult to treat. While braces and surgery are…
Not Just Cosmetic: Dermatologic Procedures as Gender-Affirming Care Botox, fillers, microneedling—these are often labeled “cosmetic,” but for many transgender patients, they serve a far deeper purpose. This article in the July…
July Article Spotlight In parts of the world where red clay soil coats the ground, podoconiosis—non-filarial elephantiasis—continues to devastate lives. This neglected tropical disease affects nearly 4 million people globally…
Beyond Minoxidil: Is It Time to Rethink Female Hair Loss Treatment? More than half of postmenopausal women, and a significant percentage of younger, healthy women, struggle with visible hair loss,…
Access Inequity in Atopic Dermatitis Care: Are Your Patients Getting Left Behind? Gentle skin care is a foundation of atopic dermatitis (AD) treatment, but what happens when patients can’t afford,…
June 25 marks World Vitiligo Day, a global recognition of a condition that affects approximately 0.5-2% of the population worldwide. Though non-life-threatening, vitiligo carries a profound psychosocial burden, disproportionately affecting…
Neoadjuvant Hedgehog Inhibitors: Gaining Ground in Mohs for BCC? A recent survey of American College of Mohs Surgery members reveals that 22% of Mohs surgeons are already using hedgehog pathway…
Researchers at NYU Langone Health and the Perlmutter Cancer Center have discovered why many patients with melanoma are resistant to current treatments and how an existing drug class is effective…
Healio profiled a new universal classification system for topical corticosteroids that could reduce confusion across countries. The system was published in the May Journal of Drugs in Dermatology in an…
Active ingredients play a critical role in the efficacy and safety of cosmeceuticals. Join Jill Waibel, MD as she shares information on the efficacy and safety of cosmeceutical formulations, highlighting…
Featured Video Abstract Check out our all new video abstract from Cheri Frey, MD, where she discusses a scientific approach to defining, evaluating, and treating pre-aging with a cosmetic regimen…
Topical Trouble Spots: Treating Hyperkeratotic Plaques with Confidence Hyperkeratotic psoriatic plaques, those dense, elevated, and heavily scaled lesions, can be particularly resistant to topical therapy. A new post hoc analysis…
Curated Hair Content: Just For You! Scarring alopecia remains a challenging and often emotionally devastating diagnosis for patients. With its potential for permanent hair loss and the frequently delayed path to…
From the Vault: Chasing the “Benjamin Button” Effect - The Art and Economics of Noninvasive Rejuvenation Inspired by the film character who ages in reverse, the so-called “Benjamin Button” effect…
Could an Eczema Treatment Also Protect the Heart? Looking at Upadacitinib and Cardiovascular Risk Atopic dermatitis (AD) may start on the skin, but its impact goes much deeper. As a…
Taming the Flare: A Practical Algorithm for Managing Atopic Dermatitis with or without Infection For patients with atopic dermatitis (AD), flares aren’t just a passing inconvenience, they can be emotionally…
Acne Awareness Month: Spotlight on Innovation, Impact, and Individualized Care June is Acne Awareness Month, a timely reminder that acne vulgaris is more than a rite of passage—it’s a complex, chronic…
If Benzoyl Peroxide Disappears: What’s Next for Acne Treatment? Benzoyl peroxide (BPO) has long been a staple in acne therapy—widely used, well-understood, and highly effective. But its future on the…
Mind the Data Gap: Treating Acne-Induced Hyperpigmentation in Deep Skin Tones Acne-induced macular hyperpigmentation (AMH) is a persistent and distressing concern for many patients with richly melanated skin, particularly those…
Could a Migraine Medication Clear Cystic Acne? A Curious Case Suggests New Possibilities What if a drug you prescribe for migraines could also help treat cystic acne? A recent JDD…
Is Your Patient’s Gut Making Their Skin More Sensitive to the Sun? Drug-induced photosensitivity is nothing new, but could the gut microbiome be influencing how severely patients react to sunlight?…
From Molecule to Medicine: Why Roflumilast Is Raising the Bar for Topical PDE4 Inhibitors Phosphodiesterase-4 (PDE4) inhibitors are having a moment, and if you’re not yet familiar with the molecular…
GLP-1RAs and Isotretinoin: A Risky Combination? Recent reports on dermatologic side effects of GLP-1 receptor agonists (GLP-1RAs) have prompted a closer look at how these drugs interact with other treatments,…
JDD From the Vault: Estrogen Deficient Skin: A Topical Option for Postmenopausal Facial Aging Have you seen this one? We’re highlighting a frequently visited JDD article from the vault that…
"Clean," "Natural," "Cruelty-Free": Why Your Patients Are Asking—and What You Need to Know With the rise of “clean beauty,” more patients are coming to dermatology visits with questions about the…
Time for a Global Standard? Rethinking Topical Corticosteroid Classification Topical corticosteroids (TCS) are a mainstay in dermatology, used to treat a wide range of skin conditions. While effective and generally…
Photodynamic Therapy for Actinic Keratosis: Can We Make It Painless? Actinic keratosis (AK), a common result of sun damage, can be a warning sign for squamous cell carcinoma. With skin…
What Happens After Isotretinoin? New Insights Into Post-Treatment Acne Care Isotretinoin remains the gold standard for treating severe acne, but relapse after treatment is common, affecting 20 to 60% of…
The Hidden Role of C. acnes in Dandruff: Beyond the Flakes Dandruff affects nearly 50% of the global population, yet its exact causes remain under ongoing investigation. While most clinicians…
Isotretinoin Dosing in Adolescents: Does Weight Change Matter? Isotretinoin remains the gold standard for treating severe nodulocystic acne, with cumulative dosing of 120-150 mg/kg shown to balance safety and efficacy. Higher…
Upadacitinib may provide additional health benefits, including reducing the risk of major adverse cardiovascular events (MACE) and venous thromboembolism (VTE). That’s according to a May Journal of Drugs in Dermatology…
Faster Relief for Seborrheic Dermatitis? A Case for Topical Roflumilast Seborrheic dermatitis is a chronic inflammatory skin condition that often frustrates patients and clinicians alike, especially during flare-ups. While topical corticosteroids…
By Allison Sit A new American Academy of Dermatology (AAD) survey shows American adults may not fully understand the benefits of sunscreen. The survey of 1,000 adults found nearly one…
What Skin Toxicities May Signal in Melanoma Patients on Immunotherapy Cutaneous immune-related adverse events (irCAEs) are among the most common side effects seen in patients receiving immune checkpoint inhibitors (ICIs)…
Test Your Knowledge! Join Dr. Alexis Carrington, Chief Dermatology Resident at George Washington University, to help understand dermatologic conditions across all skin tones. Decoding Derm: What’s the Diagnosis is a…
Painless™ PDT vs. Conventional PDT: A Quick Look at Patient Comfort in AK Treatment Actinic keratosis (AK) is one of the most common conditions treated by dermatologists, and photodynamic therapy…
Melanoma Education on Instagram: What’s Missing—Especially for Skin of Color As melanoma rates rise, with a projected 7.3% increase in new cases and 3.8% rise in mortality in 2024, the…
What to Expect When Treating SCC In Situ with Mohs Surgery While squamous cell carcinoma in situ (SCCIS) is typically considered a low-risk skin cancer, treatment decisions, especially around surgical…
EMPSGC: Why Mohs Might Be the Better Choice Endocrine Mucin Producing Sweat Gland Carcinoma (EMPSGC) is rare, low-grade, and slow-growing—but it’s not without risk. Though uncommon, recurrence and even distant…
This webinar delves into the emerging field of dermatoporosis, a chronic skin fragility condition. Participants will explore the latest translational research that bridges basic science and clinical practice, enhancing our…
From the Vault As more patients turn to the internet for guidance on pregnancy-safe skincare, dermatologists are increasingly fielding questions about what’s safe to use during pregnancy. One JDD article,…
Could Proteasome Inhibitors Offer a New Option for Pressure Injuries? Pressure injuries, especially in the sacral area, are a frequent and frustrating challenge, particularly in elderly patients. Standard care focuses…
In acknowledgement of National Melonoma and Skin Cancer Awareness Month, we are rerunning this series of Decoding Derm. Join Dr. Alexis Carrington in Decoding Dermatology: What’s the Diagnosis, as she presents a…
Knowledge is Critical for Successful Outcomes: Current Landscape of Hyaluronic Acid Filler Use in the United States When a recent article of Allure recently explored the science behind “medical-grade”…
WATCH NOW: Racial and Ethnic Representation in Atopic Dermatitis Clinical Trials With content flying at us from every direction, it’s easy to miss what matters most. That’s why JDD Corner…
Melanoma Mortality Drops Where Dermatologists Are in High Supply: Read the Data New data shows a powerful link: the more dermatologists in your area, the lower your risk of dying…
Just put some salve on it" sounds so innocuous one could follow up with, "what could possibly go wrong?" Never ask that. Yes, our skin is our living breathing barrier…
Cylindrocarcinoma: Could Mohs Surgery Be the Clear-Cut Winner? Cylindrocarcinoma—a rare malignant offshoot of benign cylindromas—poses a surgical challenge due to its potential for recurrence and metastasis. While traditional excision has…
Explore JDDonline If you’re on the hunt for expert-led, handpicked resources on psoriasis, you’re in the right place. Whether you're brushing up on the latest treatment insights or looking for…
A Fern with Far-Reaching Potential: The Role of Polypodium Leucotomos Extract in Dermatology From photoaging to pigmentary disorders, Polypodium leucotomos extract (PLE)—a botanical with notable photoprotective and anti-inflammatory properties—has emerged…
Did you miss it? By 2044, people with skin of color (SOC) will make up the majority of the U.S. population—but dermatology still lags behind in addressing their unique needs.…
Acne Treatment Without the Dry-Out: Clascoterone Cream 1% Proves Gentle on the Skin Barrier Topical acne meds often come with an unfortunate side effect: dry, irritated skin that leaves patients…
Active ingredients play a critical role in the efficacy and safety of cosmeceuticals. Join Dr. Corey L. Hartman, as he shares information on a new cosmeceutical formulation. This presentation will…
April Issue Must-Read! Hidradenitis suppurativa (HS) isn’t just painful—it’s deeply isolating. And new data reveals why: the majority of people living with HS don’t feel heard, treated, or informed. In a…
Did you miss this #acneceuticals article from April’s issue? What if your acne routine could be smarter, more personalized—and actually stick? Say hello to the new acne algorithm that’s changing…
Beyond the Granuloma: Rethinking Treatment Strategies for Generalized Granuloma Annulare Long considered a therapeutic challenge, generalized granuloma annulare (GGA) continues to defy many conventional treatment approaches. While topical steroids may…
Explore JDDonline If you’re on the hunt for expert-led, handpicked resources on atopic dermatitis, you’re in the right place. Whether you're brushing up on the latest treatment insights or looking…
Rituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review of the Literature
Could Rituximab Be the Key to Managing Epidermolysis Bullosa Acquisita? Epidermolysis bullosa acquisita (EBA) is a rare and often debilitating autoimmune blistering disease that remains notoriously difficult to manage. While…
A Breakthrough Approach to Aging Skin: Can This Cream Combat Dermatoporosis? As skin ages, it becomes fragile, thin, and prone to bruising - a condition known as dermatoporosis, which is…
By Allison Sit Dermatologist Aimee Payne, MD, PhD, is part of the second cohort of investigators with the Chan Zuckerberg Biohub New York, a research institute that is focused on harnessing…
Are Atopic Dermatitis Clinical Trials Becoming More Inclusive? Atopic dermatitis (AD) affects over 31 million people in the U.S., disproportionately impacting racial and ethnic minorities who often experience greater disease…
Can a Botanical Serum Support Hair Growth? Hair thinning and loss can be frustrating, leaving many searching for effective, non-pharmaceutical solutions. A recent 6-month study explored the potential of REVIVV®, a…
Moisturizer and Microbiome: A New Approach to AD Management? Staphylococcus aureus colonization is linked to atopic dermatitis (AD), but could topical skincare help restore balance? A moisturizer containing colloidal oatmeal and…
Test Your Knowledge! Join Dr. Alexis Carrington, Chief Dermatology Resident at George Washington University, to help understand dermatologic conditions across all skin tones. Decoding Derm: What’s the Diagnosis is a…
GLP-1 Agonists and Skin Reactions: What Dermatologists Should Know GLP-1 agonists are widely used for diabetes and weight management, but how do they impact the skin? This study reviews cutaneous…
Dupilumab for Refractory Hailey-Hailey Disease Hailey-Hailey disease (HHD) is a challenging chronic skin disorder marked by painful blisters and erosions. Treatment can be difficult, with many patients experiencing recurrent flare-ups despite…
Could GLP-1 Agonists Offer a New Approach to Hidradenitis Suppurativa? Hidradenitis Suppurativa (HS) is a challenging inflammatory skin condition often linked to obesity and metabolic dysfunction. With GLP-1 agonists gaining attention…
Spotlight on Rosacea: Beyond the Redness This National Rosacea Month April marks National Rosacea Month, a timely reminder for dermatology professionals to sharpen their diagnostic lens beyond textbook erythema. While…
Listen Now! Dermatology is always evolving, and if you haven’t caught the latest "Ask the Investigator" podcast episodes, you're missing out on game-changing insights! Hosted by the always-engaging Dr. Adam…
Featured Podcast Life's an itch sometimes….am I right? Pruritus can pick apart the fabric of one's life as both a symptom of a primary skin disease or even as a…
Looking for images for your next lecture or presentation? We’ve got you covered! In dermatology, accurate diagnosis and treatment rely heavily on recognizing how conditions present across diverse skin tones.…
Featured Podcast Even in a world of exponentially expanding systemic options both on and off label, one fact remains: topical therapy is ALWAYS on the menu. With an unprecedented array…
Did you miss this March article? Generalized pustular psoriasis (GPP) is a serious and unpredictable skin condition with limited treatment options. The Effisayil 1 trial evaluated spesolimab, a monoclonal antibody…
Prioritizing Skincare in Cancer Treatment: A Latin American Initiative Cancer treatments often lead to skin-related side effects that impact quality of life and, in some cases, treatment adherence. The Latin…
AI-Powered Personalization for Hair Loss: A Promising Alternative? With up to 50% of women and 80% of men experiencing hair loss, many turn to generic over-the-counter solutions—often with disappointing results.…
Did You Miss It? Micronized isotretinoin is an established treatment for severe nodular acne, but can it be effectively dosed once daily instead of twice? A new pilot study explores…
Articles from the Archives Lichen planus pigmentosus (LPP) remains one of dermatology's most enigmatic conditions—often presenting insidiously, confounding diagnoses, and challenging treatment plans. Whether it appears as diffuse gray-brown patches…
Acneceuticals: A New Era in Acne Care? Pharmaceuticals and procedures have long been the backbone of acne treatment, but over-the-counter skincare is playing an increasingly recognized role. This new paper…
JDD's Must Watch Feature At JDDonline, we're always looking for new ways to bring valuable dermatology research to life. One of the most dynamic and engaging features we offer is…
JAK Inhibitors in Alopecia Areata: A Case for Persistence? Oral Janus kinase inhibitors (JAKi) have emerged as a promising treatment for severe alopecia areata, with FDA-approved options now available. But…
Listen Now! If you've been snoozing on the latest JDD "Ask the Investigator" podcast episodes, consider this your wake-up call! Hosted by the ever-insightful Dr. Adam Friedman and sponsored by…
Trending Article Alopecia is more than just a cosmetic concern - it’s a significant quality-of-life issue for patients with autoimmune connective tissue diseases (ACTDs) such as SLE, MCTD, Sjogren syndrome, UCTD,…
Trichoscopy in Skin of Color: Uncovering Overlapping Alopecia Trichoscopy is a critical tool in diagnosing hair disorders, but findings can vary in skin of color, requiring a tailored approach to…
Berberine in Dermatology: A Natural Ally for Complex Skin Conditions? Berberine, a plant-derived alkaloid long used in traditional medicine, is gaining traction as a complementary therapy in dermatology. With its…























